Atrial Fibrillation in Young Patients: a Prospective Multicentre Registry

Atrial fibrillation is a rare cardiac arrhythmia in young (i.e. <= 35-year-old) patients. Etiological factors, current management and mid- to long-term outcomes remain unknown.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Lone Atrial Fibrillation Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

Up to 35 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Caen University Hospital

Caen, Normandy, 14000, France

Location status: Recruiting

Location contact

Pierre Ollitrault, MD, MSc

CONTACT

[email protected]

0231063106

About this study

Atrial Fibrillation in YOUNG patients (YOUNG-AF) is a prospective, observational, multicentric registry, including every consecutive patients aged < 35-year-old with a diagnosis of atrial fibrillation. The registry will assess demographical, physical activity, toxicologic and genetic factors, as well as current management regarding anticoagulation, anti-arrhythmic drugs and catheter ablation. As an observational registry, patient will be managed with the guidelines-directed standard-of-care.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

First episode of atrial fibrillation
Less than 35-year-old
Diagnostic by 12-lead ECG or continuous monitoring (minimal duration 30 seconds)
French Social Security number

Exclusion criteria

Transvenous cardiac implantable electronic device (insertable cardiac monitors are not an exclusion criteria)

Treatment and study plan

Primary outcomes

Composite of mortality, thromboembolic event and heart failure

Time frame: at 10-year

Incidence of all-cause mortality, symptomatic thromboembolic event and congestive heart failure at 10-year after initial diagnosis of atrial fibrillation.
Recurrent symptomatic atrial fibrillation.

Time frame: at 10-year

Incidence of symptomatic atrial fibrillation at 10-year after initial diagnosis of atrial fibrillation.

Study contacts

Contact information is provided by the study sponsor or research team.

Pierre Ollitrault, MD, MSc

CONTACT

[email protected]

0231063106

Sponsors and collaborators

Lead sponsor

University Hospital, Caen

Other

Registry information

Acronym: YOUNG-AF

Important dates

Study start: 2021
Primary completion: 2031
Study completion: 2031
First posted: Mar 2, 2021
Registry last updated: Mar 2, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting